Published in Medical Letter on the CDC and FDA, July 21st, 2002
They point to a major new trial involving 30,000 men to study the potential of vitamin E and also of a mineral, selenium, to help prevent onset of prostate cancer, which strikes about one in six men during their lifetimes.
One professor of clinical cancer prevention in Texas said the new trial is "tremendously significant," and a Cleveland Clinic physician has suggested that men enroll in the study, open to healthy men 55 and over, or 50 years and over for African American males.
In the trial, being...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.